ATP-sensitive potassium channel activation before cardioplegia. Effects on ventricular and myocyte function

Area of Science:

• Cardiovascular Research
• Myocardial Protection
• Surgical Innovation

Background:

• Potassium channel openers (PCOs) demonstrate protective effects during myocardial ischemia.
• Investigating PCOs' efficacy in preserving left ventricular (LV) and myocyte function post-cardioplegic arrest is crucial for cardiac surgery.
• Understanding PCOs' role in myocardial protection is key to improving surgical outcomes.

Purpose of the Study:

• To evaluate the protective effects of PCO pretreatment on left ventricular (LV) and myocyte function following cardioplegic arrest.
• To assess the in vitro and in vivo efficacy of PCOs in mitigating cardiac dysfunction after cardioplegic arrest.
• To determine the potential of PCOs as a cardioprotective strategy in cardiac surgery.

Main Methods:

• Quantified PCO effects on LV myocyte contractility using videomicroscopy after simulated cardioplegic arrest in porcine myocytes.
• Assessed PCO pretreatment efficacy in an in vivo porcine model of cardioplegic arrest using cardiopulmonary bypass (CPB).
• Measured LV function via preload-recruitable stroke work relation (PRSWR) pre-CPB and post-CPB separation.

Main Results:

• PCO pretreatment significantly improved LV myocyte contractility after simulated cardioplegic arrest compared to control.
• In vivo, PCO pretreatment enhanced LV function post-cardioplegic arrest, as indicated by improved PRSWR.
• A significant complication observed was refractory ventricular fibrillation in 50% of PCO-pretreated animals post-CPB.

Conclusions:

• PCO pretreatment enhances left ventricular myocyte contractile function in vitro following cardioplegic arrest.
• In vivo application of PCO pretreatment for cardioprotection is limited by the induction of refractory arrhythmogenesis.
• The potential use of PCOs as a cardioprotective strategy in cardiac surgery warrants caution due to arrhythmogenic risks.